chrisvoncsefalvay/vaers-outcomes huggingface dataset:
it's hard to even turn over in bed; it hurts; her arm is still hurting in the muscle, very much/it never really subsided; This spontaneous case was reported by a consumer and describes the occurrence of HYPOKINESIA (it's hard to even turn over in bed), PAIN (it hurts) and MYALGIA (her arm is still hurting in the muscle, very much/it never really subsided) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOKINESIA (it's hard to even turn over in bed), PAIN (it hurts) and MYALGIA (her arm is still hurting in the muscle, very much/it never really subsided). At the time of the report, HYPOKINESIA (it's hard to even turn over in bed), PAIN (it hurts) and MYALGIA (her arm is still hurting in the muscle, very much/it never really subsided) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was provided No concomitant medication was provided
Headache started three hours after shot. Vomiting and diarrhea started at midnight day of shot. Chills to follow. Headache still occurring next day morning
Severe fatigue, malaise, and muscle cramping. Lasted 48 hours, started to resolve after the initial 24hr.
Pt received Moderna Covid vaccine on 4/19/21.  She later got sick on 4/27 and went to urgent care for headaches, tingling in her nose, ringing in her ears, weakness and tenderness in her leg muscles, nausea, lumps under her arms, and rash on her arm.  She has since been to her regular doctor 3 times with little relief of symptoms except the lumps and rash have gone.  The doctor's tell her that she seems to have just had a really bad reaction to the vaccine and recommended that she not get the second dose of Moderna.  Patient called today to cancel her second appointment.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 10-NOV-2017, the patient was vaccinated with an improperly stored dose of PROQUAD (recombinant Human albumin) (strength and route were unknown) (lot#  N013863 and expiration date 31-OCT-2018) for prophylaxis (Incorrect product storage). The Merck Sterile Diluent was properly stored. No adverse event was reported. The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709; US-009507513-1810USA001951; US-009507513-1810USA001952; US-009507513-1810USA001953; US-009507513-1810USA001954; US-009507513-1810USA001955; US-009507513-1810USA001956; US-009507513-1810USA001957; US-009507513-1810USA001959.
FELT LIKE HIT BY A TRUCK; COULDN'T GET OUT OF BED; EVERYTHING HURT; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.   No concomitant medications were reported. On an unspecified date, the subject experienced felt like hit by a truck, couldn't get out of bed, and everything hurt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt like hit by a truck, couldn't get out of bed and everything hurt was not reported. This report was non-serious.
increased T waves; This spontaneous case was reported by a patient and describes the occurrence of ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED (increased T waves) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 28-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED (increased T waves). At the time of the report, ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED (increased T waves) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2022, Electrocardiogram: increased T wave. Concomitant product use was not provided by the reporter.  Approximately 2 weeks after receiving last dose patient had an increased T wave notification on smart watch which prompted patient to go and see cardiologist. The cardiologist also took an EKG which showed increased T waves, however they were not peaking. The cardiologist stated that was nothing to worry about. Patient had not taken any medication or treatments.
Patient began breaking out in hives. BENADRYL given by parent. Patient then complained her nose hurt and mother states her nose was swollen almost shut. Taken to emergency room and patient was given prednisone.
Covid-19; metallic taste; abdominal pain; Diarrhea; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste), ABDOMINAL PAIN (abdominal pain), DIARRHOEA (Diarrhea), MYALGIA (muscle aches) and COVID-19 (Covid-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient had no known drug allergies.     On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2022 at 1:00 PM, the patient experienced DYSGEUSIA (metallic taste). 14-May-2022 at 1:00 PM, the patient experienced ABDOMINAL PAIN (abdominal pain), DIARRHOEA (Diarrhea) and MYALGIA (muscle aches). On an unknown date, the patient experienced COVID-19 (Covid-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) on 14-May-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, DYSGEUSIA (metallic taste), ABDOMINAL PAIN (abdominal pain), DIARRHOEA (Diarrhea) and MYALGIA (muscle aches) had not resolved and COVID-19 (Covid-19) outcome was unknown.            Concomitant products were not provided. Patient was not taking any other medications or products within 2 weeks of starting COVID-19 treatment. Patient previously received COVID-19 vaccine.  Company Comment: This spontaneous case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected AESI of COVID-19, the unexpected events Dysgeusia, Abdominal pain, Diarrhea and the expected event Myalgia. The events occurred on an unknown date interval after receiving the third dose of mRNA-1273 Vaccine. The patient experienced the events on the same day of taking Paxlovid as treatment for COVID-19. The outcome of the events was reported as unknown. The patient's concomitant treatment of Paxlovid remain as a confounder for the occurrence of the events Dysgeusia, Abdominal pain, Diarrhea and Myalgia. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected AESI of COVID-19, the unexpected events Dysgeusia, Abdominal pain, Diarrhea and the expected event Myalgia. The events occurred on an unknown date interval after receiving the third dose of mRNA-1273 Vaccine. The patient experienced the events on the same day of taking Paxlovid as treatment for COVID-19. The outcome of the events was reported as unknown. The patient's concomitant treatment of Paxlovid remain as a confounder for the occurrence of the events Dysgeusia, Abdominal pain, Diarrhea and Myalgia. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
Swelling on left side of neck started 1/4/21.  1/9/21 pain on left side of chest under left breast started, slightly tender to the touch.
no antibody titers in antibody testing.; This case was reported by a pharmacist via call center representative and described the occurrence of therapy non-responder in a child female patient who received Hepatitis B vaccine for prophylaxis.   Co-suspect products included Hepatitis B vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 1st dose of Hepatitis B vaccine, the 2nd dose of Hepatitis B vaccine and the 3rd dose of Hepatitis B vaccine. On an unknown date, unknown after receiving Hepatitis B vaccine, Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient that was going to nursery school so they made antibody testing but no antibody titers were found for hep-B.  The patient already received 3 doses for hep-b when she was a child. The reporter consented to follow up. The gender was captured as females as customer mentioned she referring to the patient during the conversation.  No further details were provided.
Vaccine is placed in refrigerator on 22 Sep2021 and administered on 01 DEC 2021; doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator on 22 Sep2021 and administered on 01 DEC 2021) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator on 22 Sep2021 and administered on 01 DEC 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine is placed in refrigerator on 22 Sep2021 and administered on 01 DEC 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. There was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. Date place in refrigerator was 22Sep2021. Patient did not experience temperature excursion and any adverse event   No treatment medication was provided by reporter.
CLIENT COMPLAINED OF NAUSEA, HEADACHE,  PALE CLAMMY SKIN COLD TO TOUCH, SLEEPY.
57 yo male received his first yellow fever vaccine on 9/12/07 in preparation for a trip.  He left on 9/27/07, traveled to many rural areas.  On 10/10/07 began to feel feverish.  Fever continued and he returned home on 10/13/07.  At home he complained of fevers, chills, night sweats and headaches.  Saw MD on 10/20, treated with abx but symptoms worsened.  Treated for malaria (smear done but lost).  Continued to have fatigue, fever, mand headache.  Admitted to local hospital 11/23/07 for four days.  Battery of testing was negative, except serum showing signs of previous dengue infection and CSF sent for yellow fever.  Last spoke with patient in February, still with occasional night sweats and persistent fatigue.    8/15/2008 MR received for DOS 11/22-24/2007 with D/C DX: Febrile Illness, unclear etiology.  2' DX:  Dyslipidemia, Peripheral vascular disease.  Protein C deficiency and factor V Leiden mutation. Hx lower extremity deep vein thrombosis 2' to knee surgery.    Pt presented with recurrent fever and malaise x 5 weeks since returning from foreign country. ! week after returning from trip pt abruptly developed a wound in the groin area which was firm, red and tender. Resolved on abx.  Pt continued to have fatigue myalgias, flushing of face, hands and feet, headaches and night sweats. W/u essentially (-) so d/c home for supportive care.
Information has been received from a health professional concerning a 67 year old white female with hyperlipidaemia and no illness at the time of vaccination who on 29-JUN-2007 was vaccinated in the right deltoid with a second dose of pneumococcal 23v polysaccharide vaccine (lot 655592/1175F). On 29-JUN-2007 the patient developed pain and rash at the injection site lasting 4 to 5 days. Subsequently, the patient recovered. This is one of several reports from the same source. Additional information is not expected.
t103 on 11FEB94 night time w/some cold sx; real fussy & nosebleed on 15FEB94; rash began 15FEB93 stated by father called clinic;
Positive for COVID-19 after 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive for COVID-19 after 1st dose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Positive for COVID-19 after 1st dose). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive for COVID-19 after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant product was reported.  no treatment product was reported.
This spontaneous report as received from a female consumer of unknown age reporting on herself with no pertinent medical history/drug allergies or drug reactions reported. On an unknown date, the patient was vaccinated with a dose pneumococcal vaccine (manufacturer unknown) (route, anatomical location, lot# and expiration date were not reported). Other suspect therapies included influenza virus vaccine. There was not concomitant therapy reported. On 25-FEB-2015, the patient experienced a serious road traffic accident. The patient stated that the accident caused her hematoma reported as "her chest area to filled with blood and turned red". On 04-APR-2015, the patient was admitted to the hospital experienced with severe pain in her shoulder and injury area. On 06-APR-2015, the patient was found to have herpes zoster. The patient stated that she was in the 7th week of herpes zoster and the patient was still in pain and the symptoms were not subsided despite she was taking gabapentin. The outcome of herpes zoster was reported as not recovered/not resolved. The outcome of road traffic accident, pain in shoulder and pain injury area and hematoma were unknown. Additional information has been requested.    This spontaneous report as received from a female consumer of unknown age reporting on herself with no pertinent medical history/drug allergies or drug reactions reported. On an unknown date, the patient was vaccinated with a dose pneumococcal vaccine, polyvalent (manufacturer unknown) (route, anatomical location, lot# and expiration date were not reported). Other suspect therapies included influenza virus vaccine. There was not concomitant therapy reported. On 25-FEB-2015, the patient experienced a serious road traffic accident. The patient stated that the accident caused her hematoma reported as "her chest area to filled with blood and turned red". On 04-APR-2015, the patient was admitted to the hospital experienced with severe pain in her shoulder and injury area. On 06-APR-2015, the patient was found to have herpes zoster. The patient stated that she was in the 7th week of herpes zoster and the patient was still in pain and the symptoms were not subsided despite she was taking gabapentin. The outcome of herpes zoster was reported as not recovered/not resolved. The outcome of road traffic accident, pain in shoulder and pain in injury area and hematoma were unknown. Additional information has been requested.
pretty bad reaction to 1st shot; It has now been 5-6 months since he received the 1st dose/ 2nd dose has not been administered >36 days from first vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (pretty bad reaction to 1st shot) and PRODUCT DOSE OMISSION ISSUE (It has now been 5-6 months since he received the 1st dose/ 2nd dose has not been administered >36 days from first vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION COMPLICATION (pretty bad reaction to 1st shot) and PRODUCT DOSE OMISSION ISSUE (It has now been 5-6 months since he received the 1st dose/ 2nd dose has not been administered >36 days from first vaccination). In March 2021, PRODUCT DOSE OMISSION ISSUE (It has now been 5-6 months since he received the 1st dose/ 2nd dose has not been administered >36 days from first vaccination) had resolved. At the time of the report, VACCINATION COMPLICATION (pretty bad reaction to 1st shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that he had to consult different physicians to solve the issues with adverse event of vaccine first dose.  Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.     Reporter did not allow further contact
Post/vax, as pt walked to waiting room, she collapsed. She was given oxygen, immediately she responded. B/P was taken; 108/64 L/arm. She rested for 25 mins & was accompanied at all times, vitals taken every 10 mins.
arm was sore; throat was dry; Neede to clear her throat; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), DRY THROAT (throat was dry), FATIGUE (tired) and THROAT CLEARING (Neede to clear her throat) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE SODIUM (CYTOMEL) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), DRY THROAT (throat was dry), FATIGUE (tired) and THROAT CLEARING (Neede to clear her throat). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore), DRY THROAT (throat was dry), FATIGUE (tired) and THROAT CLEARING (Neede to clear her throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other treatment information was included Peppermint tea and cough drops.
Nausea, migraine headache, dizziness, fever, chills, lethargy
Patient had painful red patchy area 2-3 inches below the vaccination site. Patient saw PCP and he prescribed antibiotics for the patient,
Pt recvd 3 doses of Engerix-B on 19JUL90, 16AUG90 & 16JAN91 & it was determined that pt was a non-responder; 4th dose of Engerix-B recvd 11JUL91;
Injection site was mildly painful, swollen and red for 2-3 days but the symptoms subsided.  Then on day 7, a warm, red, lump appeared at injection site that now feels swollen and tight.
Patient experienced chest pain overnight and presented to the Emergency Department and was admitted to the hospital. Patient was discharged on 6/14/2021 with follow up with PCP and cardiology.
Peripheral neuropathy. Needles and tingling from finger tips to shoulder - bilateral. More pronounced in left arm where vaccine was administered. Sensation lasted about 30 minutes and then subsequently subsided. No treatment needed. No further symptoms the following day besides injection site soreness.
excruciating nerve pain that was shooting to her shoulders after receiving the PNEUMOV AX; This spontaneous report as received from a pharmacist refers to a 66-year-old female patient. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies included ciclopirox (PENLAC).     On 08-DEC-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # T028093 was confirmed to be valid, expiration date 24-APR-2022, 0.5 milliliter, intramuscularly for prophylaxis.   On 10-DEC-2021 at 01:00 am, the patient experienced excruciating nerve pain that was shooting to her shoulders. She was given tramadol 1 every 6 hours as needed for pain as a treatment. The patient sought medical attention- she went to the doctor. The outcome of neuralgia was unknown.   The causality assessment between the event and the suspect vaccine was not provided.
Acute appendicitis.  Required appendectomy (performed by Dr. whose contact information is provided herein).  Patient recovered.
Arthralgia, Fever, severe arm pain, extreme fatigue, chills Narrative:
According to patient she has been menopausal for 2-3 years and the day after she received the influenza vaccine she had clear vaginal discharge (patient referred to it as if she was ovulating).  Later in the month she experienced breast tenderness and on 11/13 she started her period again after 2-3 years.  She also expressed concern that she had left leg numbness (back of leg) that began on 11/11/07.  She thinks this is related to previous neck injuries and surgeries, however she has never had the back of her leg hurt.  According to the patient she has not started any new medication (including OTC, herbal or dietary supplements)
Pt reported having one seizure the evening of his vaccination and two seizures back to back the morning after his vaccination. Per neurology, pt will be admitted to an epilepsy monitoring unit to better characterize the seizures.
Injection was placed too high and too far to the front of arm, into a tendon. I have been to 2 doctors, one recommended ice - it did not work. The other says heat. Certain arm movements are terribly painful. There is still a lump in my arm, after 1 month.